Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide, being non-alcoholic steatohepatitis (NASH) its most clinically relevant form. Given the risks associated with taking a liver biopsy, the design of accurate non-invasive methods to...

Full description

Bibliographic Details
Main Authors: Patricia Marañón, Carlos Ernesto Fernández-García, Stephania C. Isaza, Esther Rey, Rocío Gallego-Durán, Rocío Montero-Vallejo, Javier Rodríguez de Cía, Javier Ampuero, Manuel Romero-Gómez, Carmelo García-Monzón, Águeda González-Rodríguez
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Biomarker Research
Subjects:
Non-alcoholic fatty liver disease
Bone morphogenetic proteins
BMP2
Non-invasive diagnosis
Hepatocytes
Online Access:https://doi.org/10.1186/s40364-022-00383-3

Internet

https://doi.org/10.1186/s40364-022-00383-3

Similar Items